Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.48 CAD | +6.67% | +9.09% | +12.94% |
10/04 | Spectral Medical Updated on Tigris Trial | MT |
10/04 | Spectral Medical Brief: Providing Tigris Trial Update; 101 patients enrolled | MT |
Sales 2024 * | 1.4M 1.02M 85.38M | Sales 2025 * | 2.5M 1.83M 152M | Capitalization | 134M 98.03M 8.18B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 95.8 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 53.6 x |
P/E ratio 2024 * |
-12
x | P/E ratio 2025 * |
-24
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.49% |
Latest transcript on Spectral Medical Inc.
1 day | +6.67% | ||
1 week | +9.09% | ||
Current month | +2.13% | ||
1 month | +3.23% | ||
3 months | -5.88% | ||
6 months | +41.18% | ||
Current year | +12.94% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Seto
CEO | Chief Executive Officer | - | 02/19/02 |
Paul Walker
CHM | Chairman | - | 01/01/01 |
John Kellum
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Walker
CHM | Chairman | - | 01/01/01 |
Anthony Bihl
BRD | Director/Board Member | 67 | 01/08/01 |
Janelle D'Alvise
BRD | Director/Board Member | 69 | 12/21/12 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.48 | +6.67% | 56,923 |
25/24/25 | 0.45 | +5.88% | 26,100 |
24/24/24 | 0.425 | -3.41% | 6,500 |
23/24/23 | 0.44 | +2.33% | 12,068 |
22/24/22 | 0.43 | -2.27% | 14,910 |
Delayed Quote Toronto S.E., April 27, 2024 at 01:29 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.94% | 97.97M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- EDT Stock